Vol.74 No.1 January 2026

Appropriate use of antimicrobial agents in patients with febrile neutropenia

Keiji Okinaka

Jpn. J. Chemother. 74 (1): 1-8, 2026

Investigation of the mutant selection window of lascufloxacin against Streptococcus pyogenes, Streptococcus pneumoniae, and Haemophilus influenzae based on the PK/PD theory

Masamitsu Kono, Hiroshi Matsumoto, Shigeki Hatakeyama, Yasuyuki Ishikawa and Muneki Hotomi

Jpn. J. Chemother. 74 (1): 9-15, 2026

Efficacy of carbapenem use reduction through antimicrobial stewardship activities targeting specific departments using the Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) in medium-sized hospitals

Tatsuya Isogawa, Yuri Seguchi and Shozo Kono

Jpn. J. Chemother. 74 (1): 16-24, 2026

Clinical predictors of the need for second-line treatment for febrile neutropenia among patients with hematological malignancies

Taku Ito, Jun Ozawa, Shunsuke Ida, Tetsuyuki Igarashi and Hiroshi Yamamoto

Jpn. J. Chemother. 74 (1): 25-33, 2026

A case of gonococcal septic arthritis with drug induced fever caused by ceftriaxone that was treated with azithromycin

Yuki Yoshioka, Yoshikazu Kobayashi, Riho Nakai, Mariko Hasegawa and Daisuke Hida

Jpn. J. Chemother. 74 (1): 34-39, 2026

A case of catheter-related bloodstream infection caused by Candida guilliermondii that was successfully treated with fosfluconazole

Atsushi Kawano, Takashi Inagaki and Yoshie Nomura

Jpn. J. Chemother. 74 (1): 40-44, 2026

Impact of the Charlson comorbidity index on trends in advice content from antimicrobial stewardship teams for patients with positive blood cultures

Takahiro Takuma

Jpn. J. Chemother. 74 (1): 45-49, 2026